DNA RNA and Cells
3 November 2013
Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & Therapy31 October 2013
FDA CLEARS COMMENCEMENT OF PHASE 3 CHRONIC HEART FAILURE TRIAL USING MESOBLAST’S PROPRIETARY CELLS28 October 2013
Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia28 October 2013
bluebird bio Announces First Patient Transplanted in Phase 2/3 Starbeam ALD-102 Study for the Treatment of CCALD27 October 2013
Medgenics Reports Positive Data with Second-Generation Viral Vectors at European Society of Gene and Cell Therapy Congress22 October 2013
Gentium Receives Marketing Authorization From the European Commission for Defitelio(R) (Defibrotide)22 October 2013
Oncolytics Biotech® Inc. Announces Progression Free Survival Data for Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer17 October 2013
International Stem Cell Corporation Announces New Data From Parkinson’s Disease Program17 October 2013
Rebiotix Begins Clinical Trial of Therapy for the Treatment of Recurrent Clostridium difficile-Associated Diarrhea16 October 2013
Isis Earns $10 Million Milestone Payment from Biogen Idec for Advancement of ISIS-DMPK Rx to Treat Myotonic Dystrophy14 October 2013
Coronado Biosciences Announces Top-Line Results From Its TRUST-I Phase 2 Clinical Trial of TSO for the Treatment of Crohn’s Disease11 October 2013
Gentium Receives Positive Opinion From EMA’s COMP for Defibrotide for the Prevention of GvHD8 October 2013
Arrowhead Completes Enrollment in Phase 1 Study of ARC-520 for the Treatment of Chronic Hepatitis B8 October 2013
Isis Earns $7 Million in Milestone Payments from GSK for Advancement of ISIS-GSK3 Rx to Treat Viral Infection4 October 2013
Tekmira Presents TKM-PLK1 Data at 6th Annual North American Neuroendocrine Tumor Society (NA-NETS) Conference4 October 2013
Isis Pharmaceuticals Advances Phase 2 Study of ISIS-SMN Rx in Infants With Spinal Muscular AtrophyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe![Newsletter La Merie Biologics](https://pipelinereview.com/wp-content/uploads/2024/02/newsletter-1.png)
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe![Newsletter new product alert](https://pipelinereview.com/wp-content/uploads/2024/02/report-alert.png)
Featured reports